Liver-Targeted gene delivery through retrograde intrabiliary infusion

Methods in Molecular Biology

Volumn 948, Issue , 2013, Pages 275-284

  Jiang, Xuan ^a,b   Ren, Yong ^a,b   Williford, John Michael ^b   Li, Zhiping ^b   Mao, Guangzhao ^c  

^a Johns Hopkins University   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

Author keywords

Liver Targeted gene delivery; Plasmid DNA; Retrograde intrabiliary infusion

Indexed keywords

NANOPARTICLE; PLASMID DNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; COMMON BILE DUCT; CONTROLLED STUDY; CYTOTOXICITY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; GENE EXPRESSION; GENE TARGETING; GENE VECTOR; HYDRODYNAMICS; INFUSION RATE; INTRABILIARY DRUG ADMINISTRATION; LIVER; NONHUMAN; PRIORITY JOURNAL; RAT; RETROGRADE INTRABILIARY INFUSION; TRANSGENE;

EID: 84934438409     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-140-0_19     Document Type: Article

References (23)

1. Nguyen TH, Ferry N (2004) Liver gene therapy: advances and hurdles. Gene Ther 11:S76-S84
2. Kren BT, Chowdhury NR, Chowdhury JR, Steer CJ (2002) Gene therapy as an alternative to liver transplantation. Liver Transpl 8:1089-1108
3. Prieto J, Herraiz M, Sangro B, Qian C, Mazzolini G, Melero I, Ruiz J (2003) The promise of gene therapy in gastrointestinal and liver diseases. Gut 52:ii49-ii54
4. Cristiano RJ, Smith LC, Kay MA, Brinkley BR, Woo SLC (1993) Hepatic gene-Therapy - efficient gene delivery and expression in primary hepatocytes utilizing a conjugated adenovirus-DNA complex. Proc Natl Acad Sci USA 90:11548-11552
5. Nathwani AC, Davidoff AM, Hanawa H, Hu YN, Hoffer FA, Nikanorov A, Slaughter C, Ng CYC, Zhou JF, Lozier JN, Mandrell TD, Vanin EF, Nienhuis AW (2002) Sustained high-level expression of human factor IX (hFIX) after liver-Targeted delivery of recombinant adenoassociated virus encoding the hFIX gene in rhesus macaques. Blood 100:1662-1669
6. Cheung ST, Tsui TY, Wang WL, Yang ZF, Wong SY, Ip YC, Luk J, Fan ST (2002) Liver as an ideal target for gene therapy: expression of CTLA4Ig by retroviral gene transfer. J Gastroenterol Hepatol 17:1008-1014
7. Jooss K, Chirmule N (2003) Immunity to adenovirus and adeno-Associated viral vectors: implications for gene therapy. Gene Ther 10:955-963
8. Cichon G, Schmidt HH, Benhidjeb T, Loser P, Ziemer S, Haas R, Grewe N, Schnieders F, Heeren J, Manns MP, Schlag PM, Strauss M (1999) Intravenous administration of recombinant adenoviruses causes thrombocytopenia, anemia and erythroblastosis in rabbits. J Gene Med 1:360-371
9. Treco DA, Selden RF (1995) Nonviral genetherapy. Mol Med Today 1:314-321
10. Herweijer H, Wolff JA (2003) Progress and prospects: naked DNA gene transfer and therapy. Gene Ther 10:453-458
11. Niidome T, Huang L (2002) Gene therapy progress and prospects: nonviral vectors. Gene Ther 9:1647-1652
12. Kawakami S, Yamashita F, Nishida K, Nakamura J, Hashida M (2002) Glycosylated cationic Liposomes for cell-selective gene delivery. Crit Rev Ther Drug Carrier Syst 19:171-190
13. Rogers JV, Bigley NJ, Chiou HC, Hull BE (2000) Targeted delivery of DNA encoding herpes simplex virus type-1 glycoprotein D enhances the cellular response to primary viral challenge. Arch Dermatol Res 292:542-549
14. Reichen J (1999) The role of the sinusoidal endothelium in liver function. News Physiol Sci 14:117-121
15. Otsuka M, Baru M, Delriviere L, Talpe S, Nur I, Gianello P (2000) In vivo liver-directed gene transfer in rats and pigs with large anionic multilamellar liposomes: routes of administration and effects of surgical manipulations on transfection ef fi ciency. J Drug Target 8:267-279
16. Zakim D, Boyer TD (2003) Hepatology: a textbook of liver disease. Saunders, Philadelphia
17. Ludwig J, Ritman EL, LaRusso NF, Sheedy PF, Zumpe G (1998) Anatomy of the human biliary system studied by quantitative computer- aided three-dimensional imaging techniques. Hepatology 27:893-899
18. Bircher J (1999) Oxford textbook of clinical hepatology. Oxford University Press, Oxford
19. Zhang XH, Collins L, Sawyer GJ, Dong XB, Qiu Y, Fabre JW (2001) In vivo gene delivery via portal vein and bile duct to individual lobes of the rat liver using a polylysine-based nonviral DNA vector in combination with chloroquine. Hum Gene Ther 12:2179-2190
20. Xie X, Forsmark CE, Lau JYN (1997) Feasibility of adenoviral-mediated gene delivery through ERCP - the effect or bile and pancreatic juice. Hepatology 26:276-276
21. Xie XM, Forsmark CE, Lau JYN (2000) Effect of bile and pancreatic juice on adenoviralmediated gene delivery - implications on the feasibility of gene delivery through ERCP. Dig Dis Sci 45:230-236
22. Tominaga K, Kuriyama S, Yoshiji H, Deguchi A, Kita Y, Funakoshi F, Masaki T, Kurokohchi K, Uchida N, Tsujimoto T, Fukui H (2004) Repeated adenoviral administration into the biliary tract can induce repeated expression of the original gene construct in rat livers without immunosuppressive strategies. Gut 53:1167-1173
23. Dai H, Jiang X, Tan GC, Chen Y, Torbenson M, Leong KW, Mao HQ (2006) Chitosan- DNA nanoparticles delivered by intrabiliary infusion enhance liver-Targeted gene delivery. Int J Nanomedicine 1:507-522